Expression of allergens in E. coli and plants--benefits and drawbacks

Breiteneder, H.; Wagner, B.

Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 94: 178-187

2003


ISSN/ISBN: 0936-8671
PMID: 15119037
Document Number: 559607
Recombinant allergens are quickly becoming the reagents of choice for diagnosis and therapy of type I allergic diseases. Consequently, the different methods for the production of recombinant proteins that are available today are of great interest to allergologists. Without doubt, bacterial expression will continue to play a pivotal role. In addition, plant-based expression systems will be needed to overcome problems inherent in the E. coli systems and to allow the production of glycoallergens or allergens of more complex folding.

Document emailed within 1 workday
Secure & encrypted payments